articleJournal of Biological ChemistryJun 1, 2002HYBRID OA

The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors

Novartis (Switzerland) · University of Virginia · +1 more institution

PubMed
Indexed incrossrefdoajpubmed

Abstract

Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis. In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation. FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms. Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the…

Citation impact

1,498
total citations
FWCI
21.39
Percentile
100%
References
36
Citations per year

Authors

13

Topics & keywords

Keywords
  • Receptor
  • Sphingosine-1-phosphate receptor
  • Sphingosine-1-phosphate
  • Immune receptor
  • Immune system
  • Chemistry
  • Cell biology
  • Sphingosine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.